Top compounds associated with response to SLC22A31


Feature Type Standardized
Nominal ANOVA
mRNA etoposide CTRPv2 pan-cancer AAC -0.061 0.04
mRNA tivozanib CTRPv2 pan-cancer AAC -0.074 0.04
mRNA Imatinib CTRPv2 pan-cancer AAC -0.072 0.04
mRNA thapsigargin gCSI pan-cancer AAC -0.12 0.04
mRNA N9-isopropylolomoucine CTRPv2 pan-cancer AAC 0.071 0.05
mRNA KX2-391 CTRPv2 pan-cancer AAC -0.062 0.05
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC -0.058 0.05
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.068 0.05
mRNA foretinib CTRPv2 pan-cancer AAC -0.068 0.05
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.065 0.05
Download CSV